Vaccine Deployment and Ebola Transmission Dynamics Estimation in Eastern DR Congo

17 Pages Posted: 2 Dec 2018 Last revised: 2 Feb 2019

See all articles by Maimuna Majumder

Maimuna Majumder

Harvard University - Department of Health Care Policy

Sherri Rose

Harvard University - Department of Health Care Policy

Date Written: December 26, 2018

Abstract

Over the last 8 months, the Democratic Republic of the Congo (DRC) has reported nearly 600 cases of Ebola virus disease (EVD). Here, we estimate transmission dynamics associated with the outbreak, the percentage of the affected population that has thus far been effectively immunized (Imm) against EVD, and case count projections under three separate transmission scenarios.

After acquiring publicly available cumulative reported case counts of EVD, the Incidence Decay and Exponential Adjustment model was used to estimate the basic (R_0) and observed (R_Obs) reproduction numbers associated with the outbreak. R_0 and R_Obs estimates were then used to assess Imm and to project case counts under Base Case (i.e. no change), Better Case, and Worse Case transmission scenarios.

R_0 and R_Obs estimates range from 1.15 to 2.58 and from 1.10 to 1.63, respectively. These estimates suggest that approximately 4% to 37% of the affected population has thus far been effectively immunized against EVD; however, we also find that an Imm rate of 13% to 61% will need to be achieved to meet the estimated herd immunity threshold. Assuming no changes in transmission dynamics, we estimate that the expected cumulative case count will range between 982 and 1472 by late March 2019 (i.e. Base Case scenario); however, Better and Worse Case scenarios result in lesser and greater case count estimates, respectively.

Though >50,000 doses of rVSV-ZEBOV have already been deployed, vaccination efforts will need to be bolstered in the weeks ahead to eliminate EBOV transmission in the DRC. Under the assumption that rVSV-ZEBOV is the primary mode of transmission suppression within the context of this outbreak, another ~35,000 to ~100,000 doses will likely need to be deployed to achieve herd immunity.

Research reported in this work was supported by the National Institutes of Health through an NIH Director’s New Innovator Award DP2-MD012722.

Keywords: Ebola, Ebola Virus Disease, EVD, rVSV-ZEBOV, vaccination, DR Congo, Democratic Republic of the Congo, DRC

Suggested Citation

Majumder, Maimuna and Rose, Sherri, Vaccine Deployment and Ebola Transmission Dynamics Estimation in Eastern DR Congo (December 26, 2018). Available at SSRN: https://ssrn.com/abstract=3291591 or http://dx.doi.org/10.2139/ssrn.3291591

Maimuna Majumder (Contact Author)

Harvard University - Department of Health Care Policy ( email )

25 Shattuck Street
Boston, MA 02115
United States

Sherri Rose

Harvard University - Department of Health Care Policy

25 Shattuck Street
Boston, MA 02115
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
46
Abstract Views
343
PlumX Metrics